Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
235 participants
INTERVENTIONAL
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MKP media versus BSK-H media
one half of skin specimen obtained from erythema migrans patients was cultivated for Borrelia burgdorferi sensu lato in MKP media and the other half in BSK-H media
MKP media
one half of skin specimen was put in MKP media
BSK-H media
one half of skin specimen was put in BSK-H media
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MKP media
one half of skin specimen was put in MKP media
BSK-H media
one half of skin specimen was put in BSK-H media
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* taking antibiotic with antiborrelial activity within 10 days
* erythema migrans localized on face or neck
Each patient (235 subjects) provided two skin samples (470 skin samples).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ljubljana School of Medicine, Slovenia
OTHER
University Medical Centre Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Franc Strle
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franc Strle, MD, PhD
Role: STUDY_DIRECTOR
UMC Ljubljana
Eva Ruzic-Sabljic, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Ljubljana School of Medicine, Slovenia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MKP,BSK-0613
Identifier Type: -
Identifier Source: org_study_id